Workshop on the Art of Writing Publishable High-Impact Research Manuscript

-


School of Chemical Engineering, Universiti Sains Malaysia (USM); in collaboration with Usains Holding Sdn. Bhd. (wholly-owned by Universiti Sains Malaysia); will be organising a workshop on The Art of Writing Publishable High-Impact Research Manuscript, which will be held as follows:

Date   :  4 July 2018 (Wednesday).
Venue: Seminar Room, School of Chemical Engineering, Engineering Campus, Universiti Sains Malaysia, Nibong Tebal, Penang.
Time  :  9:00 a.m. – 5:00 p.m.
Closing Date for Registration : 20 June 2018


SUITABLE FOR

  • ✔ Lecturers.
  • ✔ Postgraduate students.
  • ✔ Engineers.
  • ✔ Researchers.
  • ✔ Those who are interested in writing publishable high-impact research manuscript.


WORKSHOP BACKGROUND

This workshop has been conducted by Professor Dr. Bassim H. Hameed more than 50 times in the last 8 years, and has been attended by more than 1,500 university lecturers, postgraduate students, and researchers from more than 40 institutions, universities, industries, and research centres.
The main objective of the workshop is to enhance the capability of participants in writing publishable manuscripts in first-class scientific manuscript and to increase their knowledge and understanding of the processes of publishing.

FEE

Fee inclusive of GST (GST registration no: 0012 9141 9648).
Fee covers tea breaks and lunches, course materials and Certificate of Attendance.
RM 595.00 per participant
Group: RM 495.00 per participant
(Minimum of 3 participants from the same company/organisation)
Student: RM 450.00 per participant
(Applicable to Full-time student only. Proof of Student I.D. is compulsory)

Note: Workshop fee does not cover accommodation and travelling expenses.
(For company that contributes to HRDF, this workshop is claimable under the HRDF SBL Scheme – subject to HRDF approval).

MORE INFO: BROCHURE: REGISTRATION & ENQUIRIES:

Norsiah Abd Rahman
School of Chemical Engineering, Universiti Sains Malaysia.
(T) +604-599 6406
(E) ws-publish@usm.my


Comments

Robert Hohl said…
That's impressive, and you did an excellent job with the blog. Thank you for your contribution. You're doing an excellent job. You're doing a fantastic job. Take a look at this article that someone told me about What is Xbox Resolver? .When you say you want to keep your Xbox IP private from opponents and not be blacklisted.so read this article and learn a more
26 August 2022 at 18:57
Post a Comment

MUST-READS

ICT Mumbai towards getting top 100 in the world over next 10 years

-
Q&A session with prof. GD Yadav! 😁 Prof. GD Yadav, Vice Chancellor, Institute of Chemical Technology (ICT) Mumbai, aims to develop the institution towards getting it among the top 100 in the world over next 10 years. In this interview with Careers360, Prof Yadav talks about the role of teaching standards in improving the quality and ranking of an institution, the scope of industry collaboration and benefits that can come along engagement with international faculties and global universities... Read the Q&A in https://news.careers360.com/my-vision-make-ict-one-top-100-institutes-world-10-years
Read more

Taklimat Penggunaan ICESYS

-
Image
Salam semua..sedikit penerangan mengenai sistem ICESYS; Apakah rekod yang dimasukkan dalam ICESYS? ia adalah KHIDMAT dan KETERLIBATAN Bagaimanakah cara nak masukkan rekod dan proses di dalam sistem ICESYS? Apakah contoh projek keterlibatan dan bagaimana nak pilih kategorinya? Hasrat HEJIM untuk tahun 2013 dan penambahbaikkan sistem mengikut kriteria kenaikan pangkat; post by: Syaz 
Read more

Collaboration to Develop Novel Class of Drug Conjugate

-
Collaboration to Develop Novel Class of Drug Conjugate😎 "The Affimer-drug conjugate circulates as a single molecule, in which the conjugated drug is inert, until it encounters enzymes selectively expressed in tumours, where the drug is released and through its mechanism of action is designed to turn immunologically “cold” tumours “hot” and receptive to immunotherapy. It is our expectation that this will increase the percentage of responsive patients dramatically and in doing so, it will make a meaningful difference to the lives of a great many cancer patients.” https://www.labmate-online.com/news/news-and-views/5/avacta-group/collaboration-to-develop-novel-class-of-drug-conjugate/46762
Read more